One of the themes of the current tech boom has been big data, which promises to change everything from business to government, to medicine. 23andMe is a startup that offers genetic tests for $99. Earlier this week 23andMe struck a deal with the drug company Pfizer, which is paying an undisclosed sum to get the genetic information of 5,000 people in 23andMe's database.
23andMe Profits Off Big Pharma Demand for Genetic Data
Sponsored